FDA Inspection 1010562 — Angela Gernone
The FDA completed an inspection of Angela Gernone on Mar 24, 2017 in Bari. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 24, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bari (Italy)
Additional details
Clinical Investigator (CI)